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Abstract
Cigarette smoking is increased in people with trait anxiety and anxiety disorders, however no longitudinal data exist
illuminating whether smoking in adolescence can influence the developmental trajectory of anxiety symptoms from early
vulnerability in infancy to adult anxiety expression. Using The Tracing Opportunities and Problems in Childhood and
Adolescence (TOPP) Study, a community-based cohort of children and adolescents from Norway who were observed from
the age of 18months to age 18–19years, we explored the relationship between adolescent smoking, early vulnerability for
anxiety in infancy (e.g. shyness, internalizing behaviors, emotional temperaments) and reported early adult
anxiety. Structural equation modeling demonstrated that adolescent active smoking was positively associated with
increased early adulthood anxiety (b= 0.17, p,0.05), after controlling for maternal education (proxy for socioeconomic
status). Adolescent anxiety did not predict early adult smoking. Adolescent active smoking was a significant effect modifier
in the relationship between some infant vulnerability factors and later anxiety; smoking during adolescence moderated the
relationship between infant internalizing behaviors (total sample: active smokers: b= 0.85,p,0.01, non-active smokers: ns)
and highly emotional temperament (total sample: active smokers: b= 0.55,p,0.01,non-active smokers: ns), but not shyness,
and anxiety in early adulthood. The results support a model where smoking acts as an exogenous risk factor in the
development of anxiety, and smoking may alter the developmental trajectory of anxiety from infant vulnerability to early
adult anxiety symptom expression. Although alternative non-mutually exclusive models may explain these findings, the
results suggest that adolescent smoking may be a risk factor for adult anxiety, potentially by influencing anxiety
developmental trajectories. Given the known adverse health effects of cigarette smoking and significant health burden
imposed by anxiety disorders, this study supports the importance of smoking prevention and cessation programs targeting
children and adolescence.
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Introduction
Multiple population based epidemiological studies, utilizing
cross-sectional and prospective designs, have demonstrated higher
rates of cigarette smoking in individuals with anxiety disorders [1–
3] and increased anxiety symptoms [4](see review, Moylan et al [5]).
These increased rates of smoking are quite startling. For example,
data from the US National Comorbidity Study revealed rates of
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current smoking rates between 38–46% in those with an anxiety
disorder compared to 22.5% in those with no mental disorder [1].
Rates of smoking amongst those with anxiety disorders in New
Zealand were estimated at approximately 30% (compared to 20%
in those without a mental disorder) in a nationally representative
study, with those individuals consuming approximately 16% of all
cigarettes in New Zealand [3]. Despite significant investigation
[4,6–13] a complete understanding of this association remains
elusive. Such understanding is important, as it could inform
interventions aimed at reducing the morbidity associated with this
association. Three non-mutually exclusive models could explain
this association [5].
First, the observed association could be explained by shared
vulnerability, where biological and/or environmental factors
increase the likelihood of smoking and of developing increased
anxiety [14,15]. As an example, lower socioeconomic status, which
is associated with multiple disease risk factors and mental disorder
expression, is associated with both increased smoking [16,17] and
anxiety [18]. Second, anxiety may increase smoking-related
behaviors [4,19–23]. Evidence suggests individuals with increased
anxiety do display increased smoking behaviors [4,19–23], with
various factors, including an increased vulnerability to start
smoking in response to peer pressure [4,16] and use of cigarettes
for anxiety-relief, proposed as possible explanations. Finally,
smoking may predispose to increased anxiety levels through a
variety of mechanisms [20,21,24–27]. For example, smoking
adversely impacts respiratory health and autonomic control;
effects that potentially increase vulnerability for developing anxiety
[13,28–31]. Furthermore, some literature suggests a direct effect of
cigarette smoke and nicotine on normal neurodevelopment
[32,33], which may increase the chance of developing anxiety in
later life. In support, rats exposed to nicotine in early life exhibit
more anxiety-like states in adulthood than those exposed at a later
age [34].
It is possible that models proposed to explain the adverse effects
of cigarette smoke exposure on development of numerous medical
disorders may be relevant to anxiety development. Exposure to
cigarette smoke in childhood and adolescence is known to increase
adult disease expression and severity of multiple physical illnesses
[35], including aortic atherosclerosis [36] and asthma [37,38],
particularly in those with a pre-existing disease vulnerability (e.g.
family history). In these disorders, cigarette smoke may act as an
exogenous risk factor that compounds pre-existing vulnerability to
intensify disease development and severity. A similar pathogenic
model could be relevant for mental disorders: commencing
smoking at an earlier age, particularly during key stages of
neurodevelopment such as adolescence, may exacerbate an
underlying vulnerability for anxiety. In this model, exposure
cigarette smoke could alter the developmental trajectory of anxiety
through effects on underlying neurobiology [39] and leave
individuals more susceptible to increased anxiety in the long term.
These effects could result from direct effects of cigarette smoke
components (e.g. nicotine and free radicals) leading to disturbance
in the function and regulation of neurotransmitter systems (e.g. the
cholinergic system) and/or by direct cellular damage secondary to
increased oxidative and nitrosative stress. This model is supported
by recent observations that early onset smoking is associated with
shorter time to onset of anxiety disorders [40].
Some early childhood behaviors are predictive of increased
adult anxiety, including internalizing behaviors, shyness and a
highly emotional temperament [41–43]. These behaviors may be
conceptualized as early markers of an underlying risk for increased
adult anxiety. Through testing whether or not exposure to
cigarette smoke moderates the developmental trajectory of anxiety
from these early observed anxiety behaviors to adult anxiety
expression, we have the opportunity to test whether a neurode-
velopmental model could apply to anxiety development. Such
insights could provide a basis for future endeavors in further
understanding anxiety pathogenesis, and how cigarette smoke
influences this process.
This study uses a large longitudinal cohort, the Tracing
Opportunities and Problems in Childhood and Adolescence (TOPP) Study,
to assess the prospective relationship between adolescent smoking
and adult anxiety symptoms. The study tests two hypotheses: that
adolescent smoking is associated with increased early adult anxiety
symptoms, and that adolescent smoking moderates the relation-
ship between infant vulnerability for anxiety and early adult
anxiety.
Methods
Participants and Study Procedures
We used data from the TOPP Study [44], a prospective
community-based observational study of children and adolescents
from eastern Norway. In 1993, 929 families attending 18-month
vaccination visits from 19 health care areas in eastern Norway
completed the initial survey. The 19 health care areas were
representative of the diversity of Norwegian social environments.
The sample was predominantly middle class ethic Norwegian
families, 28% of whom resided in large cities, 55% in densely
populated areas and 17% rurally. Mothers were on average 30
years of age (SD=4.7; Range: 19–46years) at baseline assessment.
Data collected from child health clinics demonstrated no
association between maternal age, employment status, education,
marital status of number of children and likelihood of study
participation. The participating families were subsequently invited
to undertake further questionnaires when their children were 2–3
years, 4–5 years, 8–9 years, 12–13 years, 14–15 years, 16–17 years
and 18–19 years. The parents provided all information until the
age of 8–9 years, after which information was collected from
parents and children. All participants provided informed consent
and the study procedures were approved by the Norwegian Ethical
Committee.
At baseline, age 18months, information was available from 913
mothers on their infants (49% male), with 456 (50%) adolescent
respondents at age 14–15 and 441 (48%) adolescent respondents at
ages 18–19 years. Multiple baseline variables were tested to assess
their association with study attrition at early adulthood follow up
(age 18–19 yrs). After controlling for multiple-significance testing
via Bonferroni correction, study attrition was only significantly
related to maternal education (increased education associated with
decreased drop-out) and gender (girls with less likelihood of drop-
out). Hence gender and maternal education measured at baseline
were included and controlled for in the models.
Basic descriptive statistics for independent and dependent
variables are displayed in Table 1. Baseline maternal education,
utilized as a proxy for socioeconomic status, was assessed at
baseline using eight categories ranging from ‘‘seven years of
primary school or less’’ to ‘‘university level with four or more
years’’. During the period of schooling for some parents, Norway
had some alternative schooling options available on a limited basis
that represented items 7–8years schooling and 10 years schooling.
These are the equivalent of primary schooling and hence we have
collapsed these items down into a single category ‘‘Primary
Schooling Only’’. Maternal report of infant vulnerability factors
for anxiety was also taken from the baseline questionnaire, and
included levels of emotionality, shyness and internalizing behav-
iors. Shyness and emotionality were assessed by the Emotionality,
Adolescent Smoking and Adult Anxiety
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Activity and Sociability Temperament Survey (EAS) [45] where
each temperament trait was measured by five items rated on a 5-
point scale (1 = not typical to 5= very typical). Shyness refers to the
tendency to display inhibited and awkward behaviors in new social
situations, and emotionality refers to the tendency to become easily
and intensely aroused. Due to ambiguity in translation, one item
from emotionality scale (‘‘The child tends to be somewhat
emotional’’) and the shyness scale (‘‘ The child makes friends
easily’’) was deleted, as has been undertaken in other studies using
this dataset [43]. Factor analytic investigation of the EAS has been
undertaken in this data set, demonstrating good reliability
(Emotionality: Cronbach a=0.66; Shyness: Cronbach a=0.75)
and construct validity [46,47]. Internalizing behaviors were
assessed using two items (‘‘Has many different worries, broods
over things’’, ‘‘Is often frightened by loud noises and unexpected
things’’) from the Behaviour Checklist [48], and one additional item
pertaining to sadness (‘‘Seems often, or for long periods, to be
unhappy’’). The items for each dimension were combined into a
mean index.
Smoking (child self-report) was assessed at ages 12–13 to 18–19
years. For ages 12–13 and 14–15, respondents endorsed a four-
option categorical scale (‘‘never smoked’’, ‘‘have tried smoking’’,
‘‘sometimes smoke’’ and ‘‘daily smoker’’); for ages 16–17 and 18–
19 a five-option categorical scale (‘‘never smoked’’, ‘‘have tried
smoking’’, ‘‘former smoker, now quit’’, ‘‘sometimes smoke’’ and
‘‘daily smoker’’) was used. Due to the limitation of quite small
numbers of smokers in some categories, we decided to reclassify
smokers into a dichotomous variable – ‘‘active smoking’’ versus
‘‘non-active smoking’’ – by collapsing categories 1–2 and 3–4 at
ages 12–13 and 14–15, and categories 1–3 and 4–5 at ages 16–17
and 18–19. As only 1 respondent identified as an active smoker at
age 12–13, our analysis focused on smoking at age 14–15.
Self-report anxiety was measured at ages 12–13 and 14–15
using items from the Generalized Anxiety Disorder Scale, a
subscale of the Coolidge personality and neuropsychological
inventory for children [49]. The scale measured twelve items
drawn from DSM-IV [50] criteria for generalized anxiety
disorder, separation anxiety disorder and social phobia on a four
point continuous scale for anxiety symptoms experienced in the
last two months. At ages 16–17 & 18–19, self-report anxiety was
measured using 14 items relevant to anxiety in the Depression
Anxiety Stress Scales – 42 (DASS42 [51]). DASS42 questions
utilize a 0–3 scale, and we averaged these scores and added 1 to
gain a score between 1–4 for each respondent. Increased anxiety
scores equated to increased anxiety symptoms. This scale has
shown good reliability, convergent and discriminant validity in
non-clinical samples [52]. Additional information on validity and
reliability of scales is available elsewhere [43,46,53].
To assist the reader, the results and discussion are presented
such that age 18 months is defined as ‘‘infancy’’, age 14–15 is
defined as ‘‘adolescence’’ and age 18–19 is defined as ‘‘early
adulthood’’.
Data Analytic Procedures
Statistical analyses were undertaken using SPSS version 17 and
Mplus version 6.0 [54]. One smoker was an outlier in terms of
Table 1. Descriptive statistics of included independent and dependent variables.
Baseline Variables Frequency (%) Anxiety Mean Scores Frequency (%)
Maternal Education Anxiety - Age 14–15 yrs
#7 years Schooling 7 (0.8%) 1–1.50 337 (73.9%)
Primary Schooling Only 85 (9.3%) 1.51–2.0 81 (17.8%)
1–2 years High Schooling 245 (26.9%) 2.01–2.5 29 (6.4%)
3 years High Schooling 231 (25.4%) 2.51–3.0 7 (1.5%)
#4 years College/University 208 (22.9%) 3.01–3.5 2 (0.4%)
$4 years College/University 134 (14.7%) 3.51–4.0 0 (0.0%)
Shyness (mean score) Anxiety - Age 16–17 yrs
1–2.00 339 (37.9%) 1–1.50 294 (79.0%)
2.01–3.00 444 (48.6%) 1.51–2.0 57 (15.3%)
3.01–4.00 116 (12.7%) 2.01–2.5 14 (3.8%)
4.01–5.00 15 (1.6%) 2.51–3.0 3 (0.8%)
3.01–3.5 3 (0.8%)
Emotionality (mean score) 3.51–4.0 1 (0.2%)
1–2.00 207 (22.7%)
2.01–3.00 489 (53.6%) Anxiety - Age 18–19 yrs
3.01–4.00 185 (20.3%) 1–1.50 351 (79.6%)
4.01–5.00 32 (3.5%) 1.51–2.0 56 (12.7%)
2.01–2.5 20 (4.5%)
Internalizing (mean score) 2.51–3.0 11 (2.5%)
0–0.49 749 (81.9%) 3.01–3.5 2 (0.5%)
0.50–0.99 124 (13.6%) 3.51–4.0 1 (0.2%)
1.0–1.49 41 (4.5%)
1.50–1.99 1 (0.1%)
doi:10.1371/journal.pone.0063252.t001
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anxiety score, and was recoded to level with the next highest
anxiety score among the smokers. This procedure is in line with
recommendations by Tabachnick & Fidell [55], who recommend
recoding an outlier to a less extreme value.
A structural model was constructed in Mplus to examine how
anxiety and smoking at age 14–15 were associated with smoking
and anxiety at age 18–19. The WLSMV estimator was used due to
the categorical nature of the smoking variable. The WLSMV
estimator allows pairwise rather than listwise deletion and
performs well under the MRAX missing data assumption (where
missingness is associated with independent variables in the model)
[56]. Maternal educational level was included in the models as a
proxy for socioeconomic status [57]. We chose a priori to not
control for depression. Due to the significant overlap between the
self-reported anxiety and depressive symptoms, controlling for
depression would have unacceptably increased the risk of a type 2
error. Given the low number of boys who reported active smoking
at age 14–15 (n= 5), we only created models incorporating the
total sample and girls only.
The moderating effect of smoking on the associations between
childhood risk markers (temperamental emotionality, internalizing
problems, and temperamental shyness) and anxiety at age 18–19
was then examined by running two-group analyses in Mplus. In
these analyses the Robust Maximum Likelihood estimator was
used, allowing use of all available information and accounting for
the non-normal distribution of the measures. The associations
between childhood risk markers and anxiety at age 18–19 were
constrained to be equal among smokers and non-smokers and then
allowed to be estimated freely in the two groups in a second step of
these analyses. The fit of the unconstrained and constrained
models were then compared to test for statistically significant
differences. The smoking group was small in these analyses, and to
reduce the ratio of estimated parameters/number of observations,
the mean and variance of the maternal education variable was
identified for the smokers first and then entered into the models.
We used adjusted chi-square difference values in difference
testing of nested models as suggested by Satorra and Bentler [58].
However, in the model examining the moderating effect of
smoking on the association between early internalizing problems
and later anxiety, the adjusted chi-square difference turned out
negative, and should thus not be interpreted [59]. The ML-
estimator and regular chi-square difference was thus used in these
analyses. An alternative to this methodology would have been to
use the MLMV estimator and the diff-test option [59], but that
would have required listwise deletion and hence a reduction in the
already small active smoking group.
Results
Between ages 14–15 years (‘‘adolescence’’) 21 (4.7%) adoles-
cents (5 boys and 16 girls) self-reported active smoking. The mean
anxiety score for the early adulthood group was 1?30 (SD 0.41).
Between ages 18–19 (‘‘early adulthood’’), 85 (24.2%) adults (36
boys and 49 girls) reported active smoking and mean DASS
anxiety score for the entire sample was 1.30 (SD 0.42). Active
smoking during adolescence was correlated with active smoking in
early adulthood (r = 0.3, p,0.001). In addition, anxiety scores
during adolescence were correlated with anxiety scores during
early adulthood (r = 0.4, p,0.001). Baseline information, smoking
and anxiety scores across time points and correlations are
displayed in Tables 1, 2, 3.
Prospective relationship between adolescent smoking
and early adult anxiety symptoms
Structural Equation Modeling found no relationship between
adolescent anxiety and early adult active smoking. However, a
prospective relationship was found in the total sample between
active smoking in adolescence and early adult anxiety symptoms
(b=0.17, p,0.05). In the model utilizing data from girls only, a
prospective relationship between adolescent active smoking and
early adult anxiety symptoms was also found (b=0.20, p,0.05).
Both models showed perfect fit, as expected when all paths are
allowed to be estimated freely (chi 2 = .000, RMSEA= .000, 90%
C.I. RMSEA= .000–.000, TLI 1.00, CFI = 1.00). In both the total
sample model and girls only model, level of self-reported anxiety at
age 14–15 years was not associated with active smoking at age 18–
19 years.. See Figure 1 for both models.
Smoking as a moderator of the relationship between
vulnerability factors in infancy and later anxiety
We tested the moderating effect of adolescent active smoking on
the relationship between maternally reported temperament,
shyness and internalizing behaviors in infancy and early adult
anxiety symptom scores. Initial correlations demonstrated no
relationship between infant emotionality (temperament) (r = 0.1,
p = 0.83), shyness (r = 0.08, p = 0.12) or internalizing behaviors
(r = 0.05, p = 0.28) and early adult anxiety symptoms scores in the
total sample. However, freeing equality constraints across smoking
groups on the association between infant emotionality and early
adult anxiety, significantly improved model fit (Corrected delta
chi2 = 23.03, df = 1, p,0.01), showing that the association
between early vulnerability markers and later anxiety was
significantly different among smokers and non-smokers (age 14–
15 years). A significant positive association was discovered between
infant emotionality and early adult anxiety symptoms scores for
active smokers (b=0.55, p,0.01), that was not present for non-
active smokers (b=20.01, p.0.05) (see Figure 2). This uncon-
strained model demonstrated excellent fit (chi2 = .027, df = 2,
RMSEA= .000, 90% C.I. RMSEA= .000–.000, CFI= 1.00,
TLI= 1.71). For girls only, freeing the equality constraint across
smoking groups lead to a significant improvement of model fit
(Corrected delta chi2 = 27.01, df = 1, p,0.01), indicating that
active and non-active smokers were significantly different in
reference to the infant emotionality – early adult anxiety
association. A positive association was observed between infant
emotionality and early adult anxiety symptoms scores for active
smokers (b=0.52, p,0.01) that was not present for non-active
smokers (b=0.01, p.0.05). Again, the unconstrained model
demonstrated excellent fit (chi2 = .040, df = 2, RMSEA= .000,
90% C.I. RMSEA= .000–.000, CFI= 1.00, TLI= 4.17).
Similarly, freeing the equality constraint across smoking groups
on the association between infant internalizing behaviors and early
adult anxiety symptoms lead to significantly improved model fit
(delta Chi2 = 14.05, p,0.01, df = 1). In the total sample, this
association was significant for active smokers during adolescence
(b=0.85, p,0.01), but was not present for non-active smokers
(b=0.07, p.0.05) (see Figure 3). The fit of the unconstrained
model was excellent (chi2 = .02, df = 2, RMSEA= .000, 90% C.I.
RMSEA= .000–.000, CFI= 1.00, TLI = 1.56). Similar results
were found for the girls only model, with model fit improving
significantly when freeing the equality constraint across smoking
groups (delta Chi2 = 11.78, p,0.01, df = 1). The association
between infant internalizing symptoms and early adult anxiety
was significant for active smokers (b=0.80, p,0.01), but not for
non-active smokers (b=0.11, p.0.05) during adolescence. Fit of
Adolescent Smoking and Adult Anxiety
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the unconstrained model was excellent (chi2 = .03, df = 2,
RMSEA= .000, 90% C.I. RMSEA= .000–.000, CFI = 1.00,
TLI = 1.49).
No significant interaction was observed between infant shyness
and early adult anxiety symptoms in reference to active smoking
(b=0.08, p.0.05) versus non-active smoking (b=0.14, p.0.05)
(see Figure 4). The constrained model showed excellent fit
(chi2 = .06, df = 3, RMSEA= .000, 90% C.I. RMSEA= .000–
.000, CFI= 1.00, TLI = 1.65.) There was thus no need for a
formal test to conclude that freeing the equality constraint across
smoking groups would not improve model fit significantly. This
was the case for the girls only model as well (active smoking
(b=0.10, p.0.05), non-active smoking (b=0.15, p.0.05))
(chi2 = .06, df = 3, RMSEA= .000, 90% C.I. RMSEA= .000–
.000, CFI= 1.00, TLI = 1.00), indicating that smoking did not
moderate the shyness-later anxiety relationship. No correlation
existed between infant emotionality, internalizing behaviors or
shyness and smoking during adolescence.
Discussion
To our knowledge this is the first study to empirically test the
hypothesis that adolescent smoking moderates the relationship
between early vulnerability for anxiety and early adult anxiety
scores. We found support for this hypothesis in our data. In
addition, we demonstrated a prospective relationship between
active smoking during adolescence and increased early adult
anxiety symptoms, controlling for socioeconomic status.
In our study, both internalizing behaviors and emotionality
expressed in infancy were positively associated with early adult
anxiety symptoms, but only in those who were active smokers in
adolescence. These results suggested that smoking during adoles-
cence conferred a very large effect on the relationship between
internalizing behaviors and early adult anxiety symptoms, as well
as a moderate to large effect on the relationship between increased
emotionality and early adult anxiety symptoms. In contrast, no
differences were observed between adolescent smokers and non-
smokers in the relationship between infant shyness and early adult
anxiety.
There are several potential explanations for the observed
moderating effect of active smoking on these relationships. First, it
is possible that active smoking during adolescence in this study
captured the influence of another factor, or group of factors, that
moderate the relationship between these vulnerability behaviors
and adult anxiety scores. In this study we controlled for
socioeconomic status by utilizing maternal education as a proxy
measure, however a number of other potential moderating and
confounding factors, including individual (e.g. cognitive style) and
social factors (e.g. parental and peer smoking behaviors [60–62]),
were not available to be included in the models. It will be
important for further studies to assess whether such factors affect
Table 2. Baseline smoking and anxiety scores and correlations.
Anxiety
(14–15)
Anxiety
(16–17)
Anxiety
(18–19)
Active Smoking
(14–15)
Active Smoking
(16–17)
Active Smoking
(18–19)
Mean (SD)/Frequency Yes (%) Total;
Female
0.33 (0.38); 0.38
(0.39)
0.30 (0.39); 0.40
(0.44)
0.30 (0.42); 0.37
(0.49)
21 (4.7%); 16 (76%) 45 (4.6%); 30 (67%) 85 (24.2%); 49 (58%)
Anxiety 14–15 x r = 0.314** r = 0.405** r = 0.087 r = 0.035 r = 0.059
Anxiety 16–17 r = 0.314** x r = 0.586** r = 0.042 r = 0.283** r = 0.153*
Anxiety 18–19 r = 0.405** r = 0.586** x r = 0.165** r = 0.167** r = 0.097
Active Smoking 14–15 r = 0.087 r = 0.042 r = 0.165** x r = 0.297** r = 0.296**
Active Smoking 16–17 r = 0.035 r = 0.283** r = 0.167** r = 0.297** x r = 0.413**
Active Smoking 18–19 r = 0.059 r = 0.153* r = 0.097 r = 0.296** r = 0.413** x
Maternal Education (baseline) r =2.08 r =2.09 r = .00 r =2.07 r =2.05 r =2.11
Emotionality (baseline) r =20.101 r = 0.121 r =20.075 r =20.109 r = 0.058 r =20.105
Internalizing Behaviors (baseline) r = 0.065 r =20.035 r =20.079 r = 0.064 r = 0.001 r =20.068
Shyness (baseline) r = .12* r = .17** r = .08 r = .01 r =2.02 r =2.06
Baseline = 18 months of age,
*p,0.05,
**p,0.01.
doi:10.1371/journal.pone.0063252.t002
Table 3. Frequency of smoking reported at different age
categories.
Smoking Rates by Category Frequency (%)
Smoking Age 14–15
Never Smoked 336 (74.7%)
Have Tried Smoking 93 (20.7%)
Sometimes Smoke 13 (3.1%)
Daily Smoking 7 (1.6%)
Smoking Age 16–17
Never Smoked 199 (53.6%)
Have Tried Smoking 119 (32.1%)
Former Smoker, Now Quit 8 (2.2%)
Sometimes Smoke 31 (8.4%)
Daily Smoking 14 (3.8%)
Smoking Age 18–19
Never Smoked 130 (37%)
Have Tried Smoking 120 (34.2%)
Former Smoker, Now Quit 16 (4.6%)
Sometimes Smoke 58 (16.5%)
Daily Smoking 27 (7.7%
doi:10.1371/journal.pone.0063252.t003
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the relationship between anxiety vulnerability and later anxiety
symptoms.
In addition, it is possible that active smoking during adolescence
could represent an expected behavior in individuals with an
underlying vulnerability for anxiety as part of a developing
‘‘anxiety phenotype’’. Such a phenotype could progress from
infant anxiety vulnerability, through increasing periods of anxiety
symptoms, depressive symptoms and psychological distress in late
childhood and adolescence that predispose to increased adolescent
smoking onset, and finally to increased adult anxiety. Individuals
who do not start smoking may overcome this vulnerability
phenotype in some way, altering their anxiety trajectory.
Numerous investigations have demonstrated ‘‘anxiety sensitivity’’,
the exhibition of fear in response to anxiety-related sensations
[63,64], as being significant in influencing the association between
smoking and anxiety symptoms, potentially via increasing anxiety
reactions to smoking cues (e.g. nicotine withdrawal) [65,66].
Another possible explanation is that active smoking is a true risk
factor that modulates the translation of infant anxiety vulnerability
into early adult anxiety. Numerous potential mechanisms for how
cigarette smoking may influence anxiety expression have been
postulated. First, much investigation has explored how the effects
of smoking on the respiratory and autonomic systems may
exacerbate anxiety, particularly panic-type sympto [67]. These
outcomes may involve the disease-inducing effects of smoking,
negative health perception, and/or acute physiological effects
[13,29,31]. The primary addictive ingredient in cigarettes,
nicotine, is known to increase most measures of physiological
arousal, despite often being associated with subjective calming
effects [68], and this increased arousal may promote increased
anxiety symptoms. Second, an evolving literature suggests
exposure to cigarette smoke can adversely affect neurodevelop-
ment. The exposure to cigarette smoke in utero has been shown to
alter gene expression in areas critical to mood and anxiety control
[69], and to modify the expression of infant externalizing
behaviors [70] and other behaviors throughout the life course
[71]. Adolescence is a critical time for neurodevelopment,
characterized by pronounced changes to specific cortical func-
tioning [72], myelination [73] and synaptic connectivity [39,74].
Components of cigarette smoke including nicotine [39,75,76],
metals and free radicals [77] can exert deleterious effects on these
processes, potentially altering developmental trajectories and
leaving individuals more susceptible to increased anxiety symp-
toms in early adulthood. Although it is unlikely that the above
pathways solely explain the large moderating effects demonstrated
in the results, our data suggests that further pursuit of this area as
one component of an explanatory model for the relationship
between anxiety development and cigarette smoking may be
warranted.
In contrast to findings for internalizing behaviors and highly
emotional temperament, no difference was found between active
and non-active smokers in the relationship between infant shyness
Figure 1. Structural model of associations between active smoking and anxiety scores in adolescence (age 14–15) and early
adulthood (age 18–19). Caption: Adolescent active smoking at age 14–15 years in the total sample and for girls only was associated with
increased anxiety symptoms scores at age 18–19 years (b coefficients displayed for total sample first, then for girls only). * p,0.05, ** p,0.01. The
model is adjusted for maternal educational level. Only significant paths are shown. All paths were estimated in the model (df = 0). Model fit perfect
(x 2 = 0.00, RMSEA=0.000, TLI and CFI = 1.00). The path from Adolescent active smoking to early adult active smoking is a probit regression
coefficient. When translated into probabilities, the results show that at a mean level of maternal education and adolescent anxiety, active smoking
during adolescence has 65% risk of being active smokers in early adulthood, while non-active smokers during adolescence has a 36% risk of active-
smoking in early adulthood.
doi:10.1371/journal.pone.0063252.g001
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Figure 2. Association between childhood emotionality at 18 months and early adult anxiety scores (18–19 years) by adolescent
smoking status. Caption: Adolescent active smokers who demonstrated higher emotionality scores during infancy (18months) displayed
significantly elevated anxiety in early adulthood that was not present for non-adolescent active smokers.
doi:10.1371/journal.pone.0063252.g002
Figure 3. Association between childhood internalizing behavior scores at 18 months and early adult anxiety scores (18–19 years)
by adolescent smoking status. Caption: Adolescent active smokers who demonstrated higher internalizing behaviors during infancy (18months)
displayed significantly elevated anxiety in early adulthood that was not present for non-adolescent active smokers.
doi:10.1371/journal.pone.0063252.g003
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and early adult anxiety. Temperamental shyness is linked to
behavioral inhibition, while emotionality is often linked to
approach and pro-active behavior [78,79]. In line with this,
findings demonstrate that shyness is more strongly related to later
social anxiety than other forms of anxiety (see Coplan & Rubin
[78] for a review). Since our measure of anxiety did not include
specific items on social anxiety it’s possible that we may have failed
to observe a specific relationship in this domain of symptoms in
early adulthood. It will be important for future research to
examine how smoking moderates the relationship between early
vulnerability factors and specific sub-groups of adult anxiety.
Our modeling failed to demonstrate a prospective relationship
between increased anxiety symptoms scores at age 14–15 and
active smoking age 18–19 years. Data are conflicting [4,22,26,80]
on whether anxiety leads to increased smoking behavior [81].
Moderating factors, including peer smoking, family smoking and
socioeconomic status, appear important in smoking initiation [16],
and further investigation of adolescent smoking initiation in
populations with a pre-existing vulnerability to anxiety would be
informative.
This study has many strengths but also some limitations. The
main strength is the longitudinal follow-up of a large cohort of
participants over 18 years. The initial sample of over 900 children
was assessed at eight time periods, incorporating self-report data
from mothers and children, providing a unique opportunity to
model change throughout child development to adulthood. The
limitation of missing data that is common in longitudinal studies
was managed utilizing the WLSMV estimator in Mplus. Another
consideration is the representativeness of the study population.
Maternal education was utilized in this study to control for
socioeconomic status, as this measure has been strongly linked to
health behaviors and conscious lifestyle choices in the Norwegian
population [82], although its use is not without contention [83].
However, attrition resulted in the study population becoming
progressively skewed, such that the mean level of maternal
education increased over time. Given the inverse relationship
between socioeconomic status, maternal education and anxiety
symptoms, it is possible that both smoking and anxiety symptoms
were underrepresented in the sample. Replication of this study in a
sample with better coverage of low-SES families would be useful.
We chose a priori to not control for depression in our study, as
we believed such analysis would have unacceptably increased the
risk of type 2 error. In children and adolescents, anxiety and
depressive symptoms are highly comorbid; occurring both
sequentially and concurrently [84]. Taking into account the
longitudinal nature of our study, controlling for depression would
have masked potentially significant individual effects in children
who changed between states of anxiety and depression over time.
However, to investigate specificity of these results to anxiety, we
ran a sensitivity analysis replicating the model with a depression
scale and did not find significant effects (data not shown). We
therefore conclude that even if shared anxiety/depressive/negative
affect symptomatology is responsible for the observed effects, then
it is the anxiety component that appears to be more important.
Further, the self-report measure of smoking grouped smokers
into frequency groups, as opposed to more definitive criteria such
as quantity of cigarettes smoked. It is possible that different
reporters would have defined their smoking behavior differently
(e.g. occasional vs. daily), potentially affecting the accuracy of
smoking rates. We decided to group the relatively small number of
participants who identified themselves as ‘‘former smokers, now
quit’’ into the non-active smokers category as we felt this most
Figure 4. Association between childhood shyness at 18 months and early adult anxiety scores (18–19 years) by adolescent smoking
status. Caption: No relationship, both for adolescent active smokers and non-active smokers, was discovered between reported infant shyness at
18 months and early adult anxiety scores.
doi:10.1371/journal.pone.0063252.g004
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accurately represented their current position. However, we
acknowledge that this small group (as former smokers) may have
suffered neurodevelopmental effects during their time of smoking
that may have altered their anxiety expression, making them
similar to active smokers. Although incorrect grouping of these
participants may have influenced the results, we feel this effect
would be small (due to the small number of participants in this
category) and would lead to smaller, not larger, differences
between smoking groups. In addition, it is possible that reporters
may have been reluctant to report regular smoking in adolescence,
lowering reported smoking rates. Our smoking rates were lower
than rates of daily smoking reported in a study of Norwegian 15-
year-olds in 2005 (8.5% in boys and 9.5% in girls [85]), which may
be due to differences in our population (e.g. higher socioeconomic
status), under-reporting or a combination of both, with this
relatively low sample influencing our ability to undertake more
detailed analysis (e.g. of boys only). Nevertheless, under reporting
would have acted to attenuate observed relationships, resulting in
a more conservative set of findings. Additionally, we were unable
to report on rates of nicotine dependence in our study. Individual
smokers who are nicotine dependent demonstrate increased levels
of anxiety and depression compared to non-dependent smokers
[27], and consideration of this will be important in future
investigations. In respect to anxiety symptom measures, a different
anxiety measurement scale was utilized at age 14–15 and age 18–
19. It is possible that this change in symptom scale affected the
accuracy in tracking the development of anxiety symptoms over
time. However, the fact that anxiety symptoms correlated strongly
between time points suggests this is unlikely to have been a
significant issue. Finally, our sample did not provide information
on other potentially important variables that may influence the
relationships between adolescent smoking and anxiety, including
parental smoking, parental nicotine dependence, parental anxiety,
use of anti-depressant or anti-anxiety medications and more
detailed measures of socioeconomic circumstances. Consideration
of these factors in future investigations would be prudent.
In conclusion, this study aimed to explore whether smoking may
act as an exogenous risk factor that can alter the developmental
trajectory of anxiety from infant vulnerability to early adult
anxiety symptoms. We discovered a prospective relationship
between adolescent active smoking and early adult anxiety, and
strong moderating effects of adolescent smoking on the trajectory
of some, but not all, measures of anxiety vulnerability in infancy
and later adult anxiety symptoms. Although a number of
alternative models which themselves are not mutually exclusive
may explain these findings, the possibility that smoking is able to
exert an adverse effect on the developmental trajectory of anxiety
is not discounted by these findings and is worthy of further
investigation. Further investigation aimed at confirming this
model, coupled with efforts to understand the impact of smoking
on adolescent neurodevelopment, may afford an enhanced
understanding of how cigarette exposure contributes to anxiety
pathogenesis from a developmental perspective. These insights
could eventually inform new treatment opportunities (e.g. agents
that protect against adverse neurobiological effects) and public
health strategies. Although much remains unclear, given the
known adverse health effects of cigarette smoking, in conjunction
with the significant health burden imposed by anxiety disorders
[86,87], this study does support the importance of smoking
prevention and cessation programs targeting children and
adolescence. Smoking should be considered as one of the
potentially plastic environmental risk factors for common mental
disorders, and needs to be incorporated into prevention and
promotion efforts [88]. These efforts may exert positive effects not
just on characteristics of physical health but also on anxiety.
Author Contributions
Conceived and designed the experiments: SM KG EK SØ. Performed the
experiments: SM KG EK SØ. Analyzed the data: SM KG EK SØ. Wrote
the paper: SM KG EK SØ FJ JP MB.
References
1. Lasser K, Boyd JW, Woolhandler S, Himmelstein DU, McCormick D, et al.
(2000) Smoking and mental illness: A population-based prevalence study. JAMA
: the journal of the American Medical Association 284: 2606–2610.
2. Lawrence D, Considine J, Mitrou F, Zubrick SR (2010) Anxiety disorders and
cigarette smoking: Results from the Australian Survey of Mental Health and
Wellbeing. Aust N Z J Psychiatry 44: 520–527.
3. Tobias M, Templeton R, Collings S (2008) How much do mental disorders
contribute to New Zealand’s tobacco epidemic? Tob Control 17: 347–350.
4. Patton GC, Carlin JB, Coffey C, Wolfe R, Hibbert M, et al. (1998) Depression,
anxiety, and smoking initiation: a prospective study over 3 years. American
journal of public health 88: 1518–1522.
5. Moylan S, Jacka FN, Pasco JA, Berk M (2012) Cigarette smoking, nicotine
dependence and anxiety disorders: a systematic review of population-based,
epidemiological studies. BMC Med 10: 123.
6. Parrott AC (1998) Nesbitt’s Paradox resolved? Stress and arousal modulation
during cigarette smoking. Addiction 93: 27–39.
7. Evatt DP, Kassel JD (2010) Smoking, arousal, and affect: the role of anxiety
sensitivity. Journal of anxiety disorders 24: 114–123.
8. Buckley TC, Holohan DR, Mozley SL, Walsh K, Kassel J (2007) The effect of
nicotine and attention allocation on physiological and self-report measures of
induced anxiety in PTSD: a double-blind placebo-controlled trial. Experimental
and clinical psychopharmacology 15: 154–164.
9. Kassel JD, Bornovalova M, Mehta N (2007) Generalized expectancies for
negative mood regulation predict change in anxiety and depression among
college students. Behaviour research and therapy 45: 939–950.
10. Kassel JD, Unrod M (2000) Smoking, anxiety, and attention: support for the role
of nicotine in attentionally mediated anxiolysis. Journal of abnormal psychology
109: 161–166.
11. Kassel JD, Shiffman S (1997) Attentional mediation of cigarette smoking’s effect
on anxiety. Health psychology : official journal of the Division of Health
Psychology, American Psychological Association 16: 359–368.
12. Zvolensky MJ, Sachs-Ericsson N, Feldner MT, Schmidt NB, Bowman CJ (2006)
Neuroticism moderates the effect of maximum smoking level on lifetime panic
disorder: a test using an epidemiologically defined national sample of smokers.
Psychiatry research 141: 321–332.
13. Zvolensky MJ, Schmidt NB, McCreary BT (2003) The impact of smoking on
panic disorder: an initial investigation of a pathoplastic relationship. J Anxiety
Disord 17: 447–460.
14. Hettema JM, Prescott CA, Myers JM, Neale MC, Kendler KS (2005) The
structure of genetic and environmental risk factors for anxiety disorders in men
and women. Archives of general psychiatry 62: 182–189.
15. Reichborn-Kjennerud T, Roysamb E, Tambs K, Torgersen S, Kringlen E, et al.
(2004) Genetic and environmental influences on the association between
smoking and panic attacks in females: a population-based twin study.
Psychological medicine 34: 1271–1277.
16. Tjora T, Hetland J, Aaro LE, Øverland S (2011) Distal and proximal family
predictors of adolescents’ smoking initiation and development: a longitudinal
latent curve model analysis. BMC public health 11: 911.
17. Schaap MM, Kunst AE (2009) Monitoring of socio-economic inequalities in
smoking: learning from the experiences of recent scientific studies. Public health
123: 103–109.
18. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE (2005)
Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the
National Comorbidity Survey Replication. Archives of general psychiatry 62:
617–627.
19. Brown RA, Lewinsohn PM, Seeley JR, Wagner EF (1996) Cigarette smoking,
major depression, and other psychiatric disorders among adolescents. Journal of
the American Academy of Child and Adolescent Psychiatry 35: 1602–1610.
20. Cuijpers P, Smit F, ten Have M, de Graaf R (2007) Smoking is associated with
first-ever incidence of mental disorders: a prospective population-based study.
Addiction 102: 1303–1309.
21. Goodwin RD, Lewinsohn PM, Seeley JR (2005) Cigarette smoking and panic
attacks among young adults in the community: the role of parental smoking and
anxiety disorders. Biol Psychiatry 58: 686–693.
Adolescent Smoking and Adult Anxiety
PLOS ONE | www.plosone.org 9 May 2013 | Volume 8 | Issue 5 | e63252
22. Sonntag H, Wittchen HU, Hofler M, Kessler RC, Stein MB (2000) Are social
fears and DSM-IV social anxiety disorder associated with smoking and nicotine
dependence in adolescents and young adults? Eur Psychiatry 15: 67–74.
23. Swendsen J, Conway KP, Degenhardt L, Glantz M, Jin R, et al. (2010) Mental
disorders as risk factors for substance use, abuse and dependence: results from
the 10-year follow-up of the National Comorbidity Survey. Addiction 105:
1117–1128.
24. Breslau N, Klein DF (1999) Smoking and panic attacks: an epidemiologic
investigation. Archives of general psychiatry 56: 1141–1147.
25. Isensee B, Wittchen HU, Stein MB, Hofler M, Lieb R (2003) Smoking increases
the risk of panic: findings from a prospective community study. Arch Gen
Psychiatry 60: 692–700.
26. Johnson JG, Cohen P, Pine DS, Klein DF, Kasen S, et al. (2000) Association
between cigarette smoking and anxiety disorders during adolescence and early
adulthood. JAMA 284: 2348–2351.
27. Pedersen W, von Soest T (2009) Smoking, nicotine dependence and mental
health among young adults: a 13-year population-based longitudinal study.
Addiction 104: 129–137.
28. Niedermaier ON, Smith ML, Beightol LA, Zukowska-Grojec Z, Goldstein DS,
et al. (1993) Influence of cigarette smoking on human autonomic function.
Circulation 88: 562–571.
29. Klein DF (1993) False suffocation alarms, spontaneous panics, and related
conditions. An integrative hypothesis. Archives of general psychiatry 50: 306–
317.
30. Preter M, Klein DF (2008) Panic, suffocation false alarms, separation anxiety
and endogenous opioids. Progress in neuro-psychopharmacology & biological
psychiatry 32: 603–612.
31. Zvolensky M, Bernstein A (2005) Cigarette Smoking and Panic Psychopathol-
ogy. Current Directions in Psychological Science 14: 301–305.
32. Iniguez SD, Warren BL, Parise EM, Alcantara LF, Schuh B, et al. (2009)
Nicotine exposure during adolescence induces a depression-like state in
adulthood. Neuropsychopharmacology : official publication of the American
College of Neuropsychopharmacology 34: 1609–1624.
33. Dwyer JB, Broide RS, Leslie FM (2008) Nicotine and brain development. Birth
defects research Part C, Embryo today : reviews 84: 30–44.
34. Slawecki CJ, Gilder A, Roth J, Ehlers CL (2003) Increased anxiety-like behavior
in adult rats exposed to nicotine as adolescents. Pharmacology, biochemistry,
and behavior 75: 355–361.
35. U.S. Department of Health and Human Services (2012) PreventingTobacco Use
Among Youth and Young Adults: A Report of the Surgeon General. In: U.S.
Department of Health and Human Services., Centers for Disease Control and
Prevention, National Center for Chronic Disease Prevention and Health
Promotion, Health OoSa, editors. Atlanta: U.S. Department of Health and
Human Services.,.
36. Zieske AW, McMahan CA, McGill HC Jr, Homma S, Takei H, et al. (2005)
Smoking is associated with advanced coronary atherosclerosis in youth.
Atherosclerosis 180: 87–92.
37. Gilliland FD, Islam T, Berhane K, Gauderman WJ, McConnell R, et al. (2006)
Regular smoking and asthma incidence in adolescents. American journal of
respiratory and critical care medicine 174: 1094–1100.
38. McLeish AC, Zvolensky MJ (2010) Asthma and cigarette smoking: a review of
the empirical literature. The Journal of asthma : official journal of the
Association for the Care of Asthma 47: 345–361.
39. DeBry SC, Tiffany ST (2008) Tobacco-induced neurotoxicity of adolescent
cognitive development (TINACD): a proposed model for the development of
impulsivity in nicotine dependence. Nicotine & tobacco research : official journal
of the Society for Research on Nicotine and Tobacco 10: 11–25.
40. Jamal M, Does AJ, Penninx BW, Cuijpers P (2011) Age at smoking onset and the
onset of depression and anxiety disorders. Nicotine & tobacco research : official
journal of the Society for Research on Nicotine and Tobacco 13: 809–819.
41. Masi G, Mucci M, Favilla L, Brovedani P, Millepiedi S, et al.(2003)
Temperament in adolescents with anxiety and depressive disorders and in their
families. Child psychiatry and human development 33: 245–259.
42. Essex MJ, Kraemer HC, Armstrong JM, Boyce WT, Goldsmith HH, et al.
(2006) Exploring risk factors for the emergence of children’s mental health
problems. Archives of general psychiatry 63: 1246–1256.
43. Karevold E, Roysamb E, Ystrom E, Mathiesen KS (2009) Predictors and
pathways from infancy to symptoms of anxiety and depression in early
adolescence. Developmental psychology 45: 1051–1060.
44. Norwegian Institute of Public Health (2010) TOPP Study : Tracing
Opportunities and Problems in Childhood and Adolescence. In: Norwegian
Institute of Public Health, editor. Oslo: Norwegian Institute of Public Health,.
45. Buss AH, Plomin R (1984) Temperament : early developing personality traits.
Hillsdale, N.J.: L. Erlbaum Associates. vii, 185 p. p.
46. Mathiesen KS, Sanson A, Stoolmiller M, Karevold E (2009) The nature and
predictors of undercontrolled and internalizing problem trajectories across early
childhood. Journal of abnormal child psychology 37: 209–222.
47. Mathiesen KS, Tambs K (1999) The EAS temperament questionnaire–factor
structure, age trends, reliability, and stability in a Norwegian sample. Journal of
child psychology and psychiatry, and allied disciplines 40: 431–439.
48. Richman N, Graham PJ (1971) A behavioural screening questionnaire for use
with 3-year-old children: Preliminary findings. Journal of child psychology and
psychiatry 12: 5–33.
49. Coolidge FL, Thede LL, Stewart SE, Segal DL (2002) The Coolidge Personality
and Neuropsychological Inventory for Children (CPNI). Preliminary psycho-
metric characteristics. Behavior modification 26: 550–566.
50. American Psychiatric Association, American Psychiatric Association, Task Force
on DSM-IV, PsychiatryOnline (2000) Diagnostic and statistical manual of
mental disorders. 4th ed. Arlington, Va.: American Psychiatric Association.
51. Lovibond SH, Lovibond PF (1995) Manual for the Depression Anxiety Stress
Scales. Sydney: Psychology Foundation.
52. Crawford JR, Henry JD (2003) The Depression Anxiety Stress Scales (DASS):
normative data and latent structure in a large non-clinical sample. Br J Clin
Psychol 42: 111–131.
53. Karevold E, Ystrom E, Coplan RJ, Sanson AV, Mathiesen KS (2012) A
Prospective Longitudinal Study of Shyness from Infancy to Adolescence:
Stability, Age-Related Changes, and Prediction of Socio-Emotional Functioning.
Journal of abnormal child psychology.
54. Muthe´n L, Muthe´n B (2010) Mplus User’s Guide. In: Muthe´n M, editor. 6.0 ed.
Los Angeles: Muthe´n & Muthe´n.
55. Tabachnick BG, Fidell LS (2007) Using Multivariate Statistics: Allyn & Bacon.
56. Asparouhov T, Muthe´n B (2010) Weighted Least Squares Estimation with
Missing Data.
57. Winkleby MA, Jatulis DE, Frank E, Fortmann SP (1992) Socioeconomic status
and health: how education, income, and occupation contribute to risk factors for
cardiovascular disease. American journal of public health 82: 816–820.
58. Satorra A, Bentler P (2001) A scale difference chi-square test statistic for moment
structural analysis. Psychometrika 66: 507–514.
59. Asparouhov T, Muthe´n B (2012) Computing the Strictly Positive Satorra-
Bentler Chi-Square Test in Mplus. Mplus Web Notes. January 24, 2012 ed.
60. de Vries H, Engels R, Kremers S, Wetzels J, Mudde A (2003) Parents’ and
friends’ smoking status as predictors of smoking onset: findings from six
European countries. Health education research 18: 627–636.
61. Kelly AB, O’Flaherty M, Connor JP, Homel R, Toumbourou JW, et al. (2011)
The influence of parents, siblings and peers on pre- and early-teen smoking: a
multilevel model. Drug and alcohol review 30: 381–387.
62. Scherrer JF, Xian H, Pan H, Pergadia ML, Madden PA, et al. (2012) Parent,
sibling and peer influences on smoking initiation, regular smoking and nicotine
dependence. Results from a genetically informative design. Addictive behaviors
37: 240–247.
63. Reiss S, Peterson RA, Gursky DM, McNally RJ (1986) Anxiety sensitivity,
anxiety frequency and the prediction of fearfulness. Behaviour research and
therapy 24: 1–8.
64. McNally RJ (2002) Anxiety sensitivity and panic disorder. Biological psychiatry
52: 938–946.
65. McLeish AC, Zvolensky MJ, Bucossi MM (2007) Interaction between smoking
rate and anxiety sensitivity: relation to anticipatory anxiety and panic-relevant
avoidance among daily smokers. Journal of anxiety disorders 21: 849–859.
66. Johnson KA, Farris SG, Schmidt NB, Smits JA, Zvolensky MJ (2012) Panic
Attack History and Anxiety Sensitivity in Relation to Cognitive-Based Smoking
Processes Among Treatment-Seeking Daily Smokers. Nicotine & tobacco
research : official journal of the Society for Research on Nicotine and Tobacco.
67. Cosci F, Knuts IJ, Abrams K, Griez EJ, Schruers KR (2010) Cigarette smoking
and panic: a critical review of the literature. J Clin Psychiatry 71: 606–615.
68. Perkins KA (1995) Individual variability in responses to nicotine. Behavior
genetics 25: 119–132.
69. Mukhopadhyay P, Horn KH, Greene RM, Michele Pisano M (2010) Prenatal
exposure to environmental tobacco smoke alters gene expression in the
developing murine hippocampus. Reproductive toxicology 29: 164–175.
70. Stene-Larsen K, Borge AI, Vollrath ME (2009) Maternal smoking in pregnancy
and externalizing behavior in 18-month-old children: results from a population-
based prospective study. Journal of the American Academy of Child and
Adolescent Psychiatry 48: 283–289.
71. Liu T, Gatsonis CA, Baylin A, Kubzansky LD, Loucks EB, et al. (2011)
Maternal smoking during pregnancy and anger temperament among adult
offspring. Journal of psychiatric research 45: 1648–1654.
72. Hare TA, Tottenham N, Galvan A, Voss HU, Glover GH, et al. (2008)
Biological substrates of emotional reactivity and regulation in adolescence during
an emotional go-nogo task. Biological psychiatry 63: 927–934.
73. Paus T (2010) Growth of white matter in the adolescent brain: myelin or axon?
Brain and cognition 72: 26–35.
74. Rakic P, Bourgeois JP, Goldman-Rakic PS (1994) Synaptic development of the
cerebral cortex: implications for learning, memory, and mental illness. Progress
in brain research 102: 227–243.
75. Qiao D, Seidler FJ, Slotkin TA (2005) Oxidative mechanisms contributing to the
developmental neurotoxicity of nicotine and chlorpyrifos. Toxicology and
applied pharmacology 206: 17–26.
76. Abreu-Villaca Y, Seidler FJ, Tate CA, Slotkin TA (2003) Nicotine is a
neurotoxin in the adolescent brain: critical periods, patterns of exposure,
regional selectivity, and dose thresholds for macromolecular alterations. Brain
research 979: 114–128.
77. Tuon T, Valvassori SS, Lopes-Borges J, Fries GR, Silva LA, et al. (2010) Effects
of moderate exercise on cigarette smoke exposure-induced hippocampal
oxidative stress values and neurological behaviors in mice. Neuroscience letters
475: 16–19.
78. Coplan RJ, Rubin KH (2010) Social withdrawal and shyness in childhood:
History, theories, definitions, and assessments. In: Rubin KH, Coplan RJ,
Adolescent Smoking and Adult Anxiety
PLOS ONE | www.plosone.org 10 May 2013 | Volume 8 | Issue 5 | e63252
editors. The development of shyness and social withdrawal (Social, emotional,
and personality development in context). New York: Guilford. pp.3–22.
79. Rothbart MK, Bates JE (2006) Temperament. In: Damon NW, Lerner RM,
Eisenberg N, editors. Handbook of child psychology: Vol 3 Social, emotional
and personality development. New York: Wiley. pp.99–166.
80. McGee R, Williams S, Stanton W (1998) Is mental health in childhood a major
predictor of smoking in adolescence? Addiction 93: 1869–1874.
81. Morissette SB, Tull MT, Gulliver SB, Kamholz BW, Zimering RT (2007)
Anxiety, anxiety disorders, tobacco use, and nicotine: a critical review of
interrelationships. Psychol Bull 133: 245–272.
82. Nilsen SM, Krokstad S, Holmen TL, Westin S (2010) Adolescents’ health-
related dietary patterns by parental socio-economic position, the Nord-
Trondelag Health Study (HUNT). European journal of public health 20: 299–
305.
83. Braveman PA, Cubbin C, Egerter S, Chideya S, Marchi KS, et al. (2005)
Socioeconomic status in health research: one size does not fit all. JAMA : the
journal of the American Medical Association 294: 2879–2888.
84. Garber J, Weersing VR (2010) Comorbidity of Anxiety and Depression in
Youth: Implications for Treatment and Prevention. Clin Psychol (New York) 17:
293–306.
85. Aaro LE, Lindbak RL, Nygaard Overland S, Hetland J (2008) Use of tobacco
among Norwegian pupils in secondary school 1975–2005. Tidsskrift for den
Norske laegeforening 128: 1815–1819.
86. Stein MB, Roy-Byrne PP, Craske MG, Bystritsky A, Sullivan G, et al. (2005)
Functional impact and health utility of anxiety disorders in primary care
outpatients. Medical care 43: 1164–1170.
87. Mendlowicz MV, Stein MB (2000) Quality of life in individuals with anxiety
disorders. The American journal of psychiatry 157: 669–682.
88. Jacka FN, Mykletun A, Berk M (2012) Moving towards a population health
approach to the primary prevention of common mental disorders. BMC Med
10: 149.
Adolescent Smoking and Adult Anxiety
PLOS ONE | www.plosone.org 11 May 2013 | Volume 8 | Issue 5 | e63252
